Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-112

First 112 Last

Share
Profile

Follow
valueadd

2,896 Posts.

133

19/11/18

20:14

Post #: 36562633
Share

Originally posted by Few Pennies ↑

"I still chuckle when i see shareholders say this is going to a dollar?"
Dear NZT, In my opinion this may be one share that even a trader might want to buy and hold here's why I think that may be

If IMU's technology is successful, then I see it totally realistic that the share price won't be stopping at $1. ( even with currant issued capital at 3.6B not 3.2B).

The revenue that could be raised through a successful vaccine which could replace or augment ( but probably replace most) and become the foundation for the majority of cancer treatment around the world could within a few short years be easily raking in 5B to 10B ( AND GROWING ) in revenue and being marketed under licence between a number of big Pharma companies that I expect will be lining up to partner with us.

The royalty to Imugene on such sales could be expected to be between 10 and 20 % on sales
so on average the royalty at say 15% of say the lower figure of $5B per year of vaccine sales would be $750m.

If the IMU retain say 20% of the $750m (so $150m for R&D etc ) that leaves $600m for distribution between share holders, by which time I estimate there will be probably be close to 4B shares.

$600m per year revenue divided by 4B shares would be 15 cents per share in dividends
(when our partners are selling $10B between them all, then the dividend would be 30 cents per share).

and I suspect with the number of products IMU will have in the pipeline I expect that the dividend will continue to grow, do you think that investors won't mind to invest at least $2 per share for a share retuning 15 cents per share (and growing) dividend?

I see the large number of shares simply creating liquidity this means they are easily bought and sold
My summary
nothing wrong with the number of shares and even if one day we have over 4B shares don't worry about a $1 share price, as a share price of $2 per share could conceivably be exceeded.

Kind regards
fp

Expand

A $2.00 share price one day would be quite good l reckon . That's effectively a 100 bagger .

If that were to happen ....u'd look back and wonder what was the difference in buying at 2 cents or 3 cents .

Meanwhile on with the lawnmowing round

Lol

IMU Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
13 Upvote

1 Great analysis

Reply

Top Stories

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

MIN

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

ACW

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

WC8

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

ADD

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

RSG

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

There are more pages in this discussion • 97 more messages in this thread...

First 112 Last

Add IMU (ASX) to my watchlist

(20min delay)
Last 3.8¢		Change -0.001(2.56%)		Mkt cap ! $386.7M

Open	High	Low	Value	Volume
3.8¢	3.9¢	3.8¢	$134.8K	3.498M

Buyers (Bids)

No.	Vol.	Price($)
23	1738258	3.8¢

Sellers (Offers)

Price($)	Vol.	No.
3.9¢	494405	4

View Market Depth

No.	Vol.	Price($)
18	5665336	0.018
14	3997559	0.017
6	2974375	0.016
10	3219799	0.015
4	497500	0.014

Price($)	Vol.	No.
0.019	400000	2
0.020	5410946	12
0.021	8494780	17
0.022	8757253	13
0.023	4826614	8

Last trade - 16.10pm 29/11/2024 (20 minute delay)

IMU (ASX) Chart

Ann: Imugene Advances to Phase 2 in Gastric Cancer Trial, page-112

Top Stories

Dale Gillham's weekly wrap: Bold moves in NZ, caution in Australia

MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up

This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game

Ice-cold winner: Cryopreserver Vitrafy escapes November's IPO struggles to end debut week higher

Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects

Parkes Au-Cu project to 'transform' Adavale Resources with key targets

Resolute shares bounce back as second payment made to Mali government to secure workers' release

Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor

History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025

HotCopper Highlights: Your most watched stocks for Week 48, 2024

Buyers (Bids)

Sellers (Offers)